Cargando…
Pharmacokinetics of RP5063 Following Single Doses to Normal Healthy Volunteers and Multiple Doses Over 10 Days to Stable Schizophrenic Patients
RP5063, a multimodal dopamine (D)–serotonin (5‐HT) stabilizer, possesses high affinity for D(2/3/4) and 5‐HT(1A/2A/2B/2C/6/7) receptors and moderate affinity for the serotonin transporter. Two phase I studies characterized the pharmacokinetics of a single dose (10 and 15 mg fasting, 15 mg fed/fastin...
Autores principales: | Cantillon, Marc, Ings, Robert, Bhat, Laxminarayan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039205/ https://www.ncbi.nlm.nih.gov/pubmed/29119704 http://dx.doi.org/10.1111/cts.12518 |
Ejemplares similares
-
Initial Clinical Experience of RP5063 Following Single Doses in Normal Healthy Volunteers and Multiple Doses in Patients with Stable Schizophrenia
por: Cantillon, Marc, et al.
Publicado: (2018) -
A Population Pharmacokinetic and Pharmacodynamic Analysis of RP5063 Phase 2 Study Data in Patients with Schizophrenia or Schizoaffective Disorder
por: Cantillon, Marc, et al.
Publicado: (2018) -
Single-dose and multiple-dose pharmacokinetics of zaltoprofen after oral administration in healthy Chinese volunteers
por: Li, Lingjun, et al.
Publicado: (2011) -
Effects of Rifampin on the Pharmacokinetics of a Single Dose of Istradefylline in Healthy Subjects
por: Mukai, Mayumi, et al.
Publicado: (2017) -
Single dose pharmacokinetics of the novel transdermal donepezil patch in healthy volunteers
por: Kim, Yo Han, et al.
Publicado: (2015)